期刊文献+

结节性硬化症致病基因及基因突变研究进展 被引量:3

Progress in studies of pathogenic gene of tuberous sclerosis complex
下载PDF
导出
摘要 结节性硬化症(tuberous sclerosis complex,TSC)是一种常染色体显性遗传病,典型临床特征是癫痫、智能减退、面部血管纤维瘤及各系统的错构瘤。该病具有遗传异质性,由TSC1或TSC2基因突变引起。TSC1编码错构瘤蛋白(hamartin),TSC2编码马铃薯球蛋白(tuberin)。这两种蛋白质在组织中广泛表达,于体内形成Hamartin-Tuberin复合体,若TSC1或TSC2基因发生突变,则影响Hamartin-Tuberin二聚体功能,使mTOR复合物1(mTOR complex 1,mTORC1)信号转导通路异常激活,导致结节性硬化症的发生。目前研究证实该病与TSC1或TSC2基因突变有关。该文就结节性硬化症的致病基因及基因突变研究进展作一综述。 Tuberous sclerosis complex(TSC) is an autosomal dominant genetic disease, characterized by epilepsy, intellectual disability, facial angiofi bromas and development of hamartomas in several organs. The disease has a genetic heterogeneity, caused by mutations in one of two genes, namely TSC1 or TSC2 gene, which encodes hamartin and tuberin respectively. These two kinds of protein widely express in the organizations and form a heterodimer which lies at the crossroad of many signaling pathways. If mutations occur in either TSC1 or TSC2 gene, it would result in dysregulated mTORC1 activation, and fi nally leads to the occurrence of tuberous sclerosis complex. The current study confi rmed that TSC is caused by the mutations of TSC1 or TSC2 gene. This article reviews the research progress of TSC1 and TSC2 genes and their mutations.
作者 刘林莉 张正中 LIU Lin-li ZHANG Zheng-zkong(Department of Dermatology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Chin)
出处 《实用皮肤病学杂志》 2017年第1期44-47,共4页 Journal of Practical Dermatology
关键词 结节性硬化症 基因 TSC 遗传 Tuberous sclerosis complex Genes TSC Heredity
  • 相关文献

参考文献3

二级参考文献42

  • 1方玲,吴志英,王柠,林珉婷,慕容慎行.结节性硬化症TSC1基因编码外显子全长的突变检测与分析[J].中华神经科杂志,2005,38(2):108-111. 被引量:12
  • 2Jones AC, Sampson JR, Hoogendoorn B, et al. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis [J]. Hum Genet,2000, 106(6) :663-668.
  • 3Jones AC, Sampson JR, Cheadle JP. Low level mosaicism detectable by DHPLC but not by direct sequencing [J]. Hum Mutat, 2001,17(3) :233-234.
  • 4Choi JE, Chae JH, Hwang YS, et al. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex [J]. Brain Dev,2006,28(7) :440-446.
  • 5Lee DF, Kuo HP, Chen CT, et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the roTOR pathway[J]. Cell,2007,130(3) :440-455.
  • 6Hung CC, Su YN, Chien SC, et ah Molecular and clinical analyses of 84 patients with tuberous sclerosis complex[J]. BMC Med Genet, 2006,7: 72.
  • 7Ali M, Girimaji SC, Markandaya M, et al. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex [J]. Acla Neural Scand, 2005, 111 ( 1 ) : 54-63.
  • 8Sancak O, Nellist M, Goedbloed M, et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex [J ]. Eur J Hum Genet,2005, 13(6) :731-741.
  • 9Au KS, Williams AT, Roach ES, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States [J]. Genet Med, 2007,9 (2):88-100.
  • 10Rosner M,Hanneder M,Siegel N,et al.The mTOR pathway and its role in human genetic diseases[J].Rev Mutat Res,2008,659:284-292.

共引文献14

同被引文献19

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部